Jain Niharika, Gautam Parul, Tiwari Atul, Mittal Anjana, Gupta Naveen, Yadav Mohan Lal
Department of Pathology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Department of Pathology, JLN Medical College, Ajmer, Rajasthan, India.
Int J Appl Basic Med Res. 2022 Oct-Dec;12(4):288-290. doi: 10.4103/ijabmr.ijabmr_776_21. Epub 2022 Dec 19.
Myelodysplastic syndromes (MDSs) are clonal hematopoietic stem cell disorders characterized by cytopenias, dysplasia in one or more of the major myeloid cell lines, ineffective hematopoiesis, with cellular marrow, and risk for leukemic transformation. We present a case of a 66-year-old male with a history of multiple packed red blood cell (PRBC) transfusions. Routine investigations, bone marrow aspiration, and biopsy were done. The clinical and morphological findings raised suspicion of MDS with isolated del (5q), so cytogenetics was done. When cytogenetics was done, there was a big mismatch in finding between clinical, morphological, and molecular findings which brought a major change in prognosis as well as treatment. It is, therefore, very essential to not rely only on the clinical and morphological findings to reach a diagnosis. Molecular findings play a pivotal role to come to a final conclusion.
骨髓增生异常综合征(MDSs)是克隆性造血干细胞疾病,其特征为血细胞减少、一种或多种主要髓系细胞系发育异常、无效造血、骨髓细胞增多以及白血病转化风险。我们报告一例66岁男性病例,该患者有多次输注浓缩红细胞(PRBC)史。进行了常规检查、骨髓穿刺和活检。临床和形态学检查结果引发了对孤立性del(5q) MDS的怀疑,因此进行了细胞遗传学检查。进行细胞遗传学检查时,临床、形态学和分子学检查结果之间存在很大差异,这给预后以及治疗带来了重大改变。因此,诊断时绝不能仅依赖临床和形态学检查结果。分子学检查结果对于得出最终结论起着关键作用。